Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Ioannis M. Zacharioudakis"'
Autor:
Ioannis M. Zacharioudakis, Fainareti N. Zervou, Yanina Dubrovskaya, Kenneth Inglima, Benjamin See, Maria Aguero-Rosenfeld
Publikováno v:
International Journal of Infectious Diseases, Vol 104, Iss , Pp 354-360 (2021)
Objectives: We evaluated the value of BioFire® FilmArray® pneumonia panel in establishing a microbiological diagnosis of pneumonia. We evaluated opportunities for antimicrobial optimization from its use. Methods: We included adult patients with pne
Externí odkaz:
https://doaj.org/article/44f885965361417d877388a8f73ba5b7
Autor:
Markos Kalligeros, Ioannis M. Zacharioudakis, Giannoula S. Tansarli, Katerina Tori, Fadi Shehadeh, Eleftherios Mylonakis
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background T2Bacteria assay uses T2 magnetic resonance (T2MR) technology for the rapid diagnosis of bacterial bloodstream infections (BSIs). This FDA cleared technology can detect 5 of the most prevalent pathogens causing bacteremia (Escheri
Externí odkaz:
https://doaj.org/article/f40df394588d4892933b0e9ab0c03b9f
Autor:
Prithiv J. Prasad, Jordan Poles, Ioannis M. Zacharioudakis, Yanina Dubrovskaya, Dinuli Delpachitra, Eduardo Iturrate, Sigridh Muñoz-Gómez
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Background and objective: With the coronavirus disease 2019 (COVID-19) pandemic, rates of in-hospital antimicrobial use increased due to perceived bacterial and fungal coinfections along with COVID-19. We describe the incidence of these coi
Externí odkaz:
https://doaj.org/article/e4c956a7bfdb494298c428e6683e9b70
Autor:
Ioannis M. Zacharioudakis, Fainareti N. Zervou, Fadi Shehadeh, Evangelia K. Mylona, Eleftherios Mylonakis
Publikováno v:
EClinicalMedicine, Vol 8, Iss , Pp 12-19 (2019)
Background: Clostridioides (Clostridium) difficile ranks first among the pathogens of hospital-acquired infections with hospital-based preventive strategies being only partially successful in containing its spread. Methods: We performed a spatial sta
Externí odkaz:
https://doaj.org/article/dc328fa35891462b82a6815dd8f1874f
Autor:
Gregorio Benitez, Fadi Shehadeh, Markos Kalligeros, Evangelia K. Mylona, Quynh-Lam Tran, Ioannis M. Zacharioudakis, Eleftherios Mylonakis
Publikováno v:
Pathogens, Vol 11, Iss 5, p 555 (2022)
(1) Background: Clostridioides difficile infection (CDI) is associated with a high recurrence rate, and a significant proportion of patients with CDI are readmitted following discharge. We aimed to identify the risk factors for CDI-related readmissio
Externí odkaz:
https://doaj.org/article/be8503ff77ec4fb48bb946844f1003f9
Autor:
Kavin M. Patel, Jennie Johnson, Ioannis M. Zacharioudakis, Jerrold L. Boxerman, Timothy P. Flanigan, Rebecca M. Reece
Publikováno v:
IDCases, Vol 12, Iss , Pp 84-87 (2018)
The Powassan Virus is the arthropod-borne vector responsible for Powassan neuroinvasive disease. The virus was first isolated in 1958 and has been responsible for approximately 100 cases of neuroinvasive disease. Rates of infection have been on the r
Externí odkaz:
https://doaj.org/article/df7884babf574065b08d4f4acebaeb75
Publikováno v:
Journal of Fungi, Vol 4, Iss 2, p 45 (2018)
Invasive candidiasis is a common healthcare-associated infection with a high mortality rate that can exceed 60% in cases of septic shock. Blood culture performance is far from ideal, due to the long time to positivity and suppression by antifungal ag
Externí odkaz:
https://doaj.org/article/3f75df81c74b4b4b9f42aba42ee999b5
Publikováno v:
Future Microbiology. 17:813-817
Publikováno v:
Infection Control & Hospital Epidemiology. 41:908-913
Objective:The data regarding the effectiveness of chemical prophylaxis against recurrentC. difficileinfection (CDI) remain conflicting.Design:Retrospective cohort study on the effectiveness of oral vancomycin for prevention of recurrent CDI.Setting:T
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 94:378-384
Molecular diagnostic assays that test directly whole blood provide the ability to decrease inappropriate antimicrobial therapy and improve survival in patients with septic shock. We developed a decision analysis model to evaluate the cost-effectivene